Catalent to Buy Supplement Maker Bettera Holdings for $1 Billion

The contract drug manufacturer’s deal for closely held Bettera would expand Catalent’s manufacturing capabilities for vitamin, minerals and supplements to make them in gummy form.

What the Infrastructure Bill Would Help Fix First

Transportation officials across the U.S. are gearing up for a potential...

Covid-19 Vaccinations Boost the Global Economy, but May Not Cure It Alone

The Delta variant’s spread shows how Covid-19 can continue to slow...

Musk’s Push to Expand Tesla Driver Assistance Rankles NTSB

Tesla plans to expand access to its Full Self-Driving system and...

Universal Music Spinoff to Test Investors’ Appetite for Music

The company behind Taylor Swift and Drake is expected to list...